For instance, CSTF2 is upregulated in colon adenocarcinoma, liver cancer, uterine corpus endometrioid carcinoma, bladder urothelial carcinoma, breast invasive carcinoma, and lung adenocarcinoma [23–26]. This evidence concerns the gene CSTF2 and bladder transitional cell carcinoma.